HU905216D0 - Process for the production of heterocyclic amines and medical preparations containing them, which effect the central nerve-system - Google Patents

Process for the production of heterocyclic amines and medical preparations containing them, which effect the central nerve-system

Info

Publication number
HU905216D0
HU905216D0 HU905216A HU521690A HU905216D0 HU 905216 D0 HU905216 D0 HU 905216D0 HU 905216 A HU905216 A HU 905216A HU 521690 A HU521690 A HU 521690A HU 905216 D0 HU905216 D0 HU 905216D0
Authority
HU
Hungary
Prior art keywords
production
effect
preparations containing
heterocyclic amines
compounds
Prior art date
Application number
HU905216A
Other languages
English (en)
Other versions
HU210264B (en
HUT60269A (en
Inventor
Malcolm W Moon
Richard F Heier
Jeanette K Morris
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HU905216D0 publication Critical patent/HU905216D0/hu
Publication of HUT60269A publication Critical patent/HUT60269A/hu
Publication of HU210264B publication Critical patent/HU210264B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
HU905216A 1989-06-09 1990-05-15 Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them HU210264B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36437489A 1989-06-09 1989-06-09

Publications (3)

Publication Number Publication Date
HU905216D0 true HU905216D0 (en) 1992-02-28
HUT60269A HUT60269A (en) 1992-08-28
HU210264B HU210264B (en) 1995-03-28

Family

ID=23434241

Family Applications (2)

Application Number Title Priority Date Filing Date
HU905216A HU210264B (en) 1989-06-09 1990-05-15 Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them
HU95P/P00660P HU211702A9 (en) 1989-06-09 1995-06-30 Heterocyclic amines having central nervous system activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00660P HU211702A9 (en) 1989-06-09 1995-06-30 Heterocyclic amines having central nervous system activity

Country Status (15)

Country Link
EP (1) EP0480939B1 (hu)
JP (1) JP2955358B2 (hu)
KR (1) KR0167346B1 (hu)
AT (1) ATE117688T1 (hu)
AU (1) AU626427B2 (hu)
CA (1) CA2051697C (hu)
DE (1) DE69016430T2 (hu)
DK (1) DK0480939T3 (hu)
ES (1) ES2067744T3 (hu)
FI (2) FI96310C (hu)
HK (1) HK65397A (hu)
HU (2) HU210264B (hu)
NO (1) NO301421B1 (hu)
RU (1) RU2023712C1 (hu)
WO (1) WO1990015058A1 (hu)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
TW260660B (hu) * 1993-04-22 1995-10-21 Sumitomo Pharma
DE4314593A1 (de) * 1993-04-28 1994-11-03 Schering Ag Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln
CN1043574C (zh) * 1993-07-27 1999-06-09 法玛西雅厄普约翰美国公司 具有中枢神经系统活性的杂环胺
FR2719843B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique.
EP0705834A1 (de) * 1994-07-27 1996-04-10 Ciba-Geigy Ag Azaaliphatisch Überbrückte Chinoxalin-2,3-dione
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione
RU2170735C2 (ru) 1995-08-10 2001-07-20 Байер Аг Производные галогензамещенного бензимидазола и их кислотно-аддитивные соли, промежуточные соединения и фунгицидное средство
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2760237B1 (fr) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US6197339B1 (en) * 1997-09-30 2001-03-06 Pharmacia & Upjohn Company Sustained release tablet formulation to treat Parkinson's disease
US6455564B1 (en) * 1999-01-06 2002-09-24 Pharmacia & Upjohn Company Method of treating sexual disturbances
CN1176086C (zh) * 1999-02-05 2004-11-17 法玛西雅厄普约翰美国公司 制备(5R)-甲氨基-5,6-二氢-4H-咪唑并[4,5,1-ij]喹啉-2(1H)-酮的方法
US7074927B2 (en) 1999-05-13 2006-07-11 Pharmacia & Upjohn Company Heterocyclic amines having central nervous system activity
DE19954707A1 (de) * 1999-11-13 2001-05-17 Merck Patent Gmbh Imidazolverbindungen als Phosphodiesterase VII-Hemmer
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
DE60115872T2 (de) 2000-04-21 2006-07-13 Pharmacia & Upjohn Co. Llc, Kalamazoo Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom
AR033520A1 (es) * 2000-04-27 2003-12-26 Upjohn Co (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona
NZ524741A (en) 2000-08-16 2005-01-28 Upjohn Co Heterocyclic amines, phenylazacycloalkanes, cabergoline and aromatic bicyclic amines for the treatment of alcohol, nicotine and drug addiction
AR031200A1 (es) 2000-11-03 2003-09-10 Wyeth Corp Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados
AR031202A1 (es) 2000-11-03 2003-09-10 Wyeth Corp Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados
AR031199A1 (es) 2000-11-03 2003-09-10 Wyeth Corp Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
TW200307682A (en) 2002-04-25 2003-12-16 Wyeth Corp 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
TW200307540A (en) 2002-04-25 2003-12-16 Wyeth Corp [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
TWI312781B (en) * 2002-04-25 2009-08-01 [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
AR040683A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Composicion de tabletas de liberacion sostenida que comprende un agonista de los receptores de la dopamina
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
AR040680A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Composicion de tabletas de liberacion sostenida
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
WO2004037971A2 (en) * 2002-10-25 2004-05-06 Pharmacia & Upjohn Company Llc Use of heterocyclic amine-type compounds as neuroprotective agents
CA2533824A1 (en) * 2003-07-31 2005-02-10 Irm, Llc Bicyclic compounds and compositions as pdf inhibitors
US20050250803A1 (en) * 2003-11-26 2005-11-10 Pfizer Inc Combination of dopamine agonists and monoamine reuptake inhibitors
EP1778201B1 (en) 2004-08-13 2014-07-16 Boehringer Ingelheim International GmbH Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
BRPI0513846A (pt) 2004-08-13 2008-05-20 Boehringer Ingelheim Int formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo
PE20060939A1 (es) * 2004-11-05 2006-11-10 Wyeth Corp Metabolitos derivados de [1,4] diazepin[6,7,1-ij] quinolina y procedimiento de preparacion
GT200500317A (es) 2004-11-05 2006-10-27 Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
US7812013B2 (en) 2005-06-14 2010-10-12 Schering Corporation Macrocyclic heterocyclic aspartyl protease inhibitors
AR054849A1 (es) 2005-07-26 2007-07-18 Wyeth Corp Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
US20140080813A1 (en) 2012-09-14 2014-03-20 AbbVie Deutschland GmbH & Co. KG Tricyclic quinoline and quinoxaline derivatives
CA2884548A1 (en) 2012-09-14 2014-03-20 AbbVie Deutschland GmbH & Co. KG Tricyclic quinoline and quinoxaline derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900701260A (ko) * 1988-05-09 1990-12-01 로버트 에이. 아미테이지 2,3-디하이드로-1h-페날렌-2-아민 불안해소/우울증 방지제

Also Published As

Publication number Publication date
CA2051697C (en) 1996-10-08
HU210264B (en) 1995-03-28
EP0480939A1 (en) 1992-04-22
WO1990015058A1 (en) 1990-12-13
FI944704A0 (fi) 1994-10-07
NO914827L (no) 1992-02-07
DE69016430D1 (de) 1995-03-09
FI96310C (fi) 1996-06-10
RU2023712C1 (ru) 1994-11-30
DE69016430T2 (de) 1995-06-01
ES2067744T3 (es) 1995-04-01
HK65397A (en) 1997-05-23
KR0167346B1 (ko) 1999-01-15
CA2051697A1 (en) 1990-12-10
JPH04506071A (ja) 1992-10-22
FI96687C (fi) 1996-08-12
KR920701204A (ko) 1992-08-11
HU211702A9 (en) 1995-12-28
AU5743890A (en) 1991-01-07
FI944704A (fi) 1994-10-07
ATE117688T1 (de) 1995-02-15
EP0480939B1 (en) 1995-01-25
AU626427B2 (en) 1992-07-30
FI915715A0 (fi) 1991-12-04
FI96310B (fi) 1996-02-29
NO301421B1 (no) 1997-10-27
JP2955358B2 (ja) 1999-10-04
HUT60269A (en) 1992-08-28
FI96687B (fi) 1996-04-30
NO914827D0 (no) 1991-12-06
DK0480939T3 (da) 1995-07-10

Similar Documents

Publication Publication Date Title
HU905216D0 (en) Process for the production of heterocyclic amines and medical preparations containing them, which effect the central nerve-system
FI102175B (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten v almistamiseksi
GEP20053475B (en) Arylmethyl-Carbonylamino-Thiazole Derivatives, and Their Use as Antitumor Agents
HUP0401849A2 (hu) Kinuklidinszármazékok, ezeket tartalmazó gyógyászati készítmények, továbbá ezek alkalmazása M2 és/vagy M3 muszkarin receptor inhibitorként
HUT43599A (en) Process for production of derivatives of thiazolidindion and medical compounds containing those
KR0142801B1 (en) Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring t
FI883402A (fi) Esternitratderivat.
FR2581063B1 (fr) Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
IT1255178B (it) N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
ATE101040T1 (de) Derivate und analoge von pyrimidon zur behandlung von asthma und bestimmte hautkrankheiten.
YU46706B (sh) Postupak za dobijanje amidnih jedinjenja
KR900012893A (ko) 치환된-아세트 아미드 화합물 및 그 제조방법
KR920701122A (ko) 신규 이환식 아미노-치환 화합물
HUT49879A (en) Process for producing new 1',2'-dihydrospiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient
WO1999024421A8 (en) Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
ATE236634T1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
ES8101045A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
NO160851C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv steroidforbindelse.
FI831068A0 (fi) Foerfarande foer framstaellning av enantiomerer av substituerade fenylazacykloalkaner med farmaceutaktivitet
PT85429A (en) Process for the preparation of pharmaceutical compositions
DE69010606D1 (de) 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee